CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise against rare liver virus
Disease control Recruiting nowThis study tests a new medicine called brelovitug for people with chronic hepatitis delta, a serious liver infection. About 80 adults will either get the drug right away or wait a few weeks before starting it. The goal is to see if brelovitug can lower the virus level and improve…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to outshine current therapy for rare liver virus
Disease control Recruiting nowThis study tests a new medicine, BJT-778, against an existing one, bulevirtide, for people with chronic hepatitis delta, a serious liver infection. About 172 adults will receive either drug for long-term control of the virus. The goal is to see if BJT-778 can better lower virus l…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC